Note: Ingredients listed on restricted chemical lists
EC/CAS
200-636-0/66-81-9
Name of the chemical
Cycloheximid
Concentration
37,5≤x<40
EC/CAS
207-838-8/497-19-8
Name of the chemical
Sodium carbonate
Concentration
1,5≤x<2
General Information
Revision date
2023-10-27
Product name
ALOA SELECTIVE SUPPLEMENT
Product name
ALOA SELECTIVE SUPPLEMENT
Identification on the label/Trade name
Biolife Italiana S.r.l
1.2.1 Relevant identified uses
Laboratory chemical. Reagent for microbiology
Emergency telephone
0845 4647
Icons in SDS
Company Information
company name
Biolife Italiana S.r.l
e-mail address of the competent person responsible for the Safety Data Sheet
mktg@biolifeitaliana.it
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H300, H315, H317, H334, H341, H360, H411
Hazard statements
Code
Statements
H300
Fatal if swallowed
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
The product is classified as hazardous pursuant to the provisions set forth in (EC) Regulation
2.2 Label elements
Hazard labelling pursuant to EC Regulation
Signal word
Danger
Hazard statements
H341 Suspected of causing genetic defects. H360 May damage fertility or the unborn child. H300 Fatal if swallowed. H315 Causes skin irritation. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 May cause an allergic skin reaction. H411 Toxic to aquatic life with long lasting effects. Restricted to professional users.
Precautionary statements
P261 Avoid breathing dust / fume / gas / mist / vapours / spray. P201 Obtain special instructions before use. P280 Wear protective gloves/ protective clothing / eye protection / face protection. P308+P313 IF exposed or concerned: Get medical advice / attention. P301+P310 IF SWALLOWED: Immediately call a POISON CENTER / doctor / . . . P342+P311 If experiencing respiratory symptoms: Call a POISON CENTER / doctor / . . .
Contains
CYCLOHEXIMIDE CEFTAZIDIME HYDRATE NALIDIXIC ACID SODIUM SALT POLYMIXIN B SULFATE
2.3 Other hazards
On the basis of available data, the product does not contain any PBT or vPvB in percentage ≥ than 0,1%. The product does not contain substances with endocrine disrupting properties in concentration ≥ 0.1%.
